GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » YIFAN PHARMACEUTICAL CO LTD (SZSE:002019) » Definitions » Cyclically Adjusted PS Ratio

YIFAN PHARMACEUTICAL CO (SZSE:002019) Cyclically Adjusted PS Ratio : 3.53 (As of May. 26, 2024)


View and export this data going back to 2004. Start your Free Trial

What is YIFAN PHARMACEUTICAL CO Cyclically Adjusted PS Ratio?

As of today (2024-05-26), YIFAN PHARMACEUTICAL CO's current share price is ¥13.54. YIFAN PHARMACEUTICAL CO's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was ¥3.84. YIFAN PHARMACEUTICAL CO's Cyclically Adjusted PS Ratio for today is 3.53.

The historical rank and industry rank for YIFAN PHARMACEUTICAL CO's Cyclically Adjusted PS Ratio or its related term are showing as below:

SZSE:002019' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 2.64   Med: 6.55   Max: 13.67
Current: 3.52

During the past years, YIFAN PHARMACEUTICAL CO's highest Cyclically Adjusted PS Ratio was 13.67. The lowest was 2.64. And the median was 6.55.

SZSE:002019's Cyclically Adjusted PS Ratio is ranked worse than
70.79% of 743 companies
in the Drug Manufacturers industry
Industry Median: 2.11 vs SZSE:002019: 3.52

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

YIFAN PHARMACEUTICAL CO's adjusted revenue per share data for the three months ended in Mar. 2024 was ¥1.090. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is ¥3.84 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


YIFAN PHARMACEUTICAL CO Cyclically Adjusted PS Ratio Historical Data

The historical data trend for YIFAN PHARMACEUTICAL CO's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

YIFAN PHARMACEUTICAL CO Cyclically Adjusted PS Ratio Chart

YIFAN PHARMACEUTICAL CO Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.81 6.00 5.09 3.33 3.90

YIFAN PHARMACEUTICAL CO Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.77 3.89 3.62 3.90 2.89

Competitive Comparison of YIFAN PHARMACEUTICAL CO's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - General subindustry, YIFAN PHARMACEUTICAL CO's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


YIFAN PHARMACEUTICAL CO's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, YIFAN PHARMACEUTICAL CO's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where YIFAN PHARMACEUTICAL CO's Cyclically Adjusted PS Ratio falls into.



YIFAN PHARMACEUTICAL CO Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

YIFAN PHARMACEUTICAL CO's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=13.54/3.84
=3.53

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

YIFAN PHARMACEUTICAL CO's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, YIFAN PHARMACEUTICAL CO's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=1.09/115.2271*115.2271
=1.090

Current CPI (Mar. 2024) = 115.2271.

YIFAN PHARMACEUTICAL CO Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 0.582 98.200 0.683
201409 0.702 98.900 0.818
201412 0.912 99.000 1.061
201503 0.536 99.900 0.618
201506 0.607 99.500 0.703
201509 1.381 100.500 1.583
201512 0.560 100.600 0.641
201603 0.723 102.200 0.815
201606 0.850 101.400 0.966
201609 0.871 102.400 0.980
201612 0.746 102.600 0.838
201703 0.782 103.200 0.873
201706 0.918 103.100 1.026
201709 1.069 104.100 1.183
201712 1.080 104.500 1.191
201803 1.040 105.300 1.138
201806 0.898 104.900 0.986
201809 0.905 106.600 0.978
201812 0.982 106.500 1.062
201903 0.926 107.700 0.991
201906 1.151 107.700 1.231
201909 1.046 109.800 1.098
201912 1.127 111.200 1.168
202003 1.065 112.300 1.093
202006 1.164 110.400 1.215
202009 1.105 111.700 1.140
202012 1.086 111.500 1.122
202103 0.998 112.662 1.021
202106 0.902 111.769 0.930
202109 0.905 112.215 0.929
202112 0.838 113.108 0.854
202203 0.747 114.335 0.753
202206 0.687 114.558 0.691
202209 0.716 115.339 0.715
202212 0.860 115.116 0.861
202303 0.769 115.116 0.770
202306 0.842 114.558 0.847
202309 0.785 115.339 0.784
202312 0.927 114.781 0.931
202403 1.090 115.227 1.090

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


YIFAN PHARMACEUTICAL CO  (SZSE:002019) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


YIFAN PHARMACEUTICAL CO Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of YIFAN PHARMACEUTICAL CO's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


YIFAN PHARMACEUTICAL CO (SZSE:002019) Business Description

Traded in Other Exchanges
N/A
Address
No. 50 Qinshan, Jincheng, Lin'an Economic Development Zone, Hangzhou, Zhejiang, CHN, 311300
YIFAN PHARMACEUTICAL CO LTD is a China-based company engaged in pharmaceutical innovation and manufacturing. The company focuses its activities on key areas like macromolecular biologics, high-value pharmaceuticals, and differentiated traditional Chinese medicines. The products of the company are F-627 for Neutropenia and Parkinson's disease, F-652 for acute alcoholic hepatitis, GvHD and acute pancreatitis and F-899 for growth deficiency. The company's products are sold in China and internationally.
Executives
Ye Yi Qun Director
Zhang Da Wei Executives
Geng Yu Hong Executives
Feng De Qi Directors, Directors, and Executives
Zhou Ben Yu Director
Lin Xing Directors, executives
Yu Hai Xia Executives
Cheng Xian Feng Directors, executives
Xu Guo Han Supervisors
Cao Shi Mei Director
Lin Guan Yu Director
Zhang Lian Chun Executives
Guo Xin Fu Director
Zheng Shi Ming Supervisors
Yin Hang Hua Executives

YIFAN PHARMACEUTICAL CO (SZSE:002019) Headlines

No Headlines